Haystack is looking forward to attending the ASCO Gastrointestinal Cancers Annual Symposium taking place January 19-21 in San Francisco, CA. ASCO GI will be celebrating 20 years of offering the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care. If you’re there, please stop by table #43 and learn about Haystack’s MRD test that delivers unmatched ctDNA detection sensitivity and accuracy for superior post-surgical treatment management.
Two leading oncologists take a deep dive into how groundbreaking advancements are providing a clearer crystal ball for guiding patient care
January 21, 2025
“The key is, MRD is actually telling us that there is circulating evidence of a residual ember, right there in this patient.” – Dr Doug Flora. When there is residual disease detected, the doctor and patient can work together to
